Alzheimer's disease & dementia

FDA OKs marketing of new test to help diagnose Alzheimer's disease

The U.S. Food and Drug Administration granted marketing approval for the Lumipulse G β-Amyloid Ratio (1-42/1-40) test, the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer disease, ...

Alzheimer's disease & dementia

New Alzheimer's biomarker may facilitate rapid diagnosis

Although symptoms of advanced Alzheimer's disease are well known, diagnosis of Alzheimer's disease in its earliest stages requires careful cognitive testing by neurologists.

Alzheimer's disease & dementia

Interferon drives cognitive impairment in Alzheimer's disease model

Alzheimer's disease (AD), the most common type of dementia, progressively impairs memory, concentration and the ability to learn new things and accomplish everyday activities. Although scientists do not yet fully understand ...

Alzheimer's disease & dementia

Key signaling pathway in immune cells could be new Alzheimer's target

Inhibiting an important signaling pathway in brain-resident immune cells may calm brain inflammation and thereby slow the disease process in Alzheimer's and some other neurodegenerative diseases, suggests a study by Weill ...

page 8 from 40